Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 8-K Material Event for the period ending Wednesday, May 10, 2017

Acro Biomedical Co., Ltd.

HISTORY TOOLS
CIK: 1622996 Ticker: ACBM

View differences made from one to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits

Exhibit 16.1: Letter To The Securities And Exchange
Ticker: ACBM
CIK: 1622996
Form Type: 8-K Corporate News
Accession Number: 0001640334-17-000937
Submitted to the SEC: Fri May 12 2017 5:24:49 PM EST
Accepted by the SEC: Fri May 12 2017
Period: Wednesday, May 10, 2017
Industry: Amusement And Recreation Services
Events:
  1. Accountant Change
  2. Financial Exhibit
  3. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acbm/0001640334-17-000937.htm